Avai Bio (AVAI) Current Deferred Tax Assets (2018 - 2020)

Avai Bio has disclosed Current Deferred Tax Assets across 3 years of filings, most recently posting -$14078.0 for Q1 2020.

• Current Deferred Tax Assets for Q1 2020 came in at -$14078.0, up 15.1% year-over-year; the trailing twelve-month figure through Mar 2020 was -$14078.0 (up 15.1% YoY), and the FY2020 annual result was -$14078.0, up 15.1% from the prior year.
• Current Deferred Tax Assets came in at -$14078.0 for Q1 2020 at Avai Bio, up from -$16582.0 in the prior quarter.
• In the past five years, Current Deferred Tax Assets ranged from a high of -$155.0 in Q1 2018 to a low of -$16582.0 in Q1 2019.
• The 3-year median for Current Deferred Tax Assets is -$7689.8 (2020), against an average of -$8029.2.
• Across the five-year window, Current Deferred Tax Assets plunged 10598.06% in 2019 and increased 15.1% in 2020, its largest moves.
• Avai Bio's Current Deferred Tax Assets stood at -$1301.6 in 2018, then plunged by 1173.96% to -$16582.0 in 2019, then gained by 15.1% to -$14078.0 in 2020.
• The last three Current Deferred Tax Assets figures came in at -$14078.0 (Q1 2020), -$16582.0 (Q1 2019), and -$1301.6 (Q2 2018), per Business Quant data.